First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects
首次人体研究,旨在评估BMS-962212(一种直接、可逆的小分子因子XIa抑制剂)在非日本籍和日本籍健康受试者中的安全性、药代动力学和药效学。
期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.13520
Perera, Vidya; Luettgen, Joseph M; Wang, Zhaoqing; Frost, Charles E; Yones, Cynthia; Russo, Cesare; Lee, John; Zhao, Yue; LaCreta, Frank P; Ma, Xuewen; Knabb, Robert M; Seiffert, Dietmar; DeSouza, Mary; Mugnier, Pierre; Cirincione, Brenda; Ueno, Takayo; Frost, Robert J A